These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1304619)

  • 1. Decreased superoxide dismutase activity in erythrocyte in Parkinson's disease.
    Urakami K; Sano K; Matsushima E; Okada A; Saito H; Takahashi K; Ikebuchi J; Mura T; Ikawa S
    Jpn J Psychiatry Neurol; 1992 Dec; 46(4):933-6. PubMed ID: 1304619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Superoxide dismutase activity in early and advanced Parkinson's disease.
    Bostantjopoulou S; Kyriazis G; Katsarou Z; Kiosseoglou G; Kazis A; Mentenopoulos G
    Funct Neurol; 1997; 12(2):63-8. PubMed ID: 9238339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythrocyte superoxide dismutase activity differs in clinical subgroups of Parkinson's disease patients.
    Akbostanci MC; Kocatürk PA; Tan FU; Kavas GO
    Acta Neurol Belg; 2001 Sep; 101(3):180-3. PubMed ID: 11817268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydroxyl radical and superoxide dismutase in blood of patients with Parkinson's disease: relationship to clinical data.
    Ihara Y; Chuda M; Kuroda S; Hayabara T
    J Neurol Sci; 1999 Nov; 170(2):90-5. PubMed ID: 10561523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum antioxidant enzyme activity in Parkinson's disease.
    Kalra J; Rajput AH; Mantha SV; Prasad K
    Mol Cell Biochem; 1992 Mar; 110(2):165-8. PubMed ID: 1584206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum glutathione peroxidase, xanthine oxidase, and superoxide dismutase activities and malondialdehyde levels in patients with Parkinson's disease.
    Gökçe Çokal B; Yurtdaş M; Keskin Güler S; Güneş HN; Ataç Uçar C; Aytaç B; Durak ZE; Yoldaş TK; Durak İ; Çubukçu HC
    Neurol Sci; 2017 Mar; 38(3):425-431. PubMed ID: 27900485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral blood cell activities of monoamine oxidase B and superoxide dismutase in Parkinson's disease.
    Checkoway H; Costa LG; Woods JS; Castoldi AF; Lund BO; Swanson PD
    J Neural Transm Park Dis Dement Sect; 1992; 4():283-90. PubMed ID: 1388699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythrocyte antioxidant enzymes in Parkinson's disease.
    Abraham S; Soundararajan CC; Vivekanandhan S; Behari M
    Indian J Med Res; 2005 Feb; 121(2):111-5. PubMed ID: 15756044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutrophil function, nitric oxide, and blood oxidative stress in Parkinson's disease.
    Gatto EM; Carreras MC; Pargament GA; Riobo NA; Reides C; Repetto M; Fernandez Pardal MM; Llesuy S; Poderoso JJ
    Mov Disord; 1996 May; 11(3):261-7. PubMed ID: 8723142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selegiline and lymphocyte superoxide dismutase activities in Parkinson's disease.
    Kushleika J; Checkoway H; Woods JS; Moon JD; Smith-Weller T; Franklin GM; Swanson PD
    Ann Neurol; 1996 Mar; 39(3):378-81. PubMed ID: 8602757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human aging brain disorders: role of antioxidant enzymes.
    de la Torre MR; Casado A; López-Fernández ME; Carrascosa D; Casado MC; Venarucci D; Venarucci V
    Neurochem Res; 1996 Aug; 21(8):885-8. PubMed ID: 8895840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pergolide mesylate, a dopaminergic receptor agonist, applied with L-DOPA enhances serum antioxidant enzyme activity in Parkinson disease.
    Chalimoniuk M; Stepień A; Strosznajder JB
    Clin Neuropharmacol; 2004; 27(5):223-9. PubMed ID: 15602103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Copper, ceruloplasmin, superoxide dismutase and iron parameters in Parkinson's disease.
    Tórsdóttir G; Kristinsson J; Sveinbjörnsdóttir S; Snaedal J; Jóhannesson T
    Pharmacol Toxicol; 1999 Nov; 85(5):239-43. PubMed ID: 10608487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activities of superoxide dismutase in erythrocyte of nonalcoholic chronic liver diseases.
    Ozenirler S; Tuncer C; Ongun O; Altan N; Kandilci U
    Gen Pharmacol; 1994 Nov; 25(7):1349-51. PubMed ID: 7896045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-related changes of superoxide dismutase activity in patients with schizophrenia.
    Đorđević VV; Lazarević D; Ćosić V; Knežević M; Đorđević VB
    Vojnosanit Pregl; 2017 Jan; 74(1):31-7. PubMed ID: 29350504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Superoxide dismutase level in human erythrocytes and its clinical application to the patients with cancers and thyroidal dysfunctions.
    Saito T
    Hokkaido Igaku Zasshi; 1987 Mar; 62(2):257-68. PubMed ID: 3610027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral blood markers of oxidative stress in Parkinson's disease.
    Younes-Mhenni S; Frih-Ayed M; Kerkeni A; Bost M; Chazot G
    Eur Neurol; 2007; 58(2):78-83. PubMed ID: 17565220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased mitochondrial superoxide dismutase activity in Parkinson's disease but not amyotrophic lateral sclerosis motor cortex.
    Radunović A; Porto WG; Zeman S; Leigh PN
    Neurosci Lett; 1997 Dec; 239(2-3):105-8. PubMed ID: 9469667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Red cell system and selected red cell enzymes in men occupationally exposed to mercury vapours].
    Zabiński Z; Rutowski J; Moszczyński P; Dabrowski Z
    Przegl Lek; 2006; 63 Suppl 7():74-83. PubMed ID: 17784549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Measurement of plasma malondialdehyde contents and erythrocyte superoxide dismutase activities in patients with chronic cor pulmonale].
    Cheng P
    Zhonghua Jie He He Hu Xi Za Zhi; 1991 Oct; 14(5):271-2, 318. PubMed ID: 1819377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.